Cover Image

Monoclonal antibodies for Alzheimer disease: statistical significance vs clinical efficacy

None.

Saved in:

Bibliographic Details
Main Authors:	Einstein Francisco Camargos (Author), Claudia Kimie Suemoto (Author), Paulo Caramelli (Author)
Format:	Book
Published:	Brazilian Society of Geriatrics and Gerontology, 2024-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Monoclonal Antibody Therapy in Alzheimer's Disease
by: Monica Neațu, et al.
Published: (2023)

Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease
by: Alvaro Barrera-Ocampo
Published: (2024)

Anti-Amyloid-β Monoclonal Antibodies: Recent Therapeutic Strategies for Alzheimer's Disease
by: Maria Teresa Cruz, et al.
Published: (2022)

Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: Predictions using an integrated Alzheimer's Disease Platform
by: Tatiana Karelina, et al.
Published: (2021)

Hypnotics: evidence vs practice
by: Einstein Francisco Camargos, et al.
Published: (2022)

Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions
by: Valeria Ferla, et al.
Published: (2024)

Monoclonal Antibodies and Its Clinical Aspects
by: Mohamadu Maharuf Mohamed Shafras, et al.
Published: (2018)

Monoclonal Antibodies
Published: (2021)

Monoclonal Antibodies
by: Christian Klein (Ed.)
Published: (2018)

Covid-19 vs. BCG Universal Immunization: Statistical Significance in the Early Phase of the Pandemics
by: Serge Dolgikh
Published: (2021)

Monoclonal Antibody-Directed Therapy
Published: (2022)

Monoclonal Antibodies as Neurological Therapeutics
by: Panagiotis Gklinos, et al.
Published: (2021)

Monoclonal antibodies in pediatric allergy
by: Amelia Licari, et al.
Published: (2015)

Coping in aged people with Alzheimer's disease Coping en ancianos con la enfermedad de Alzheimer Coping em idosos com doença de Alzheimer
by: Juliana Nery de Souza, et al.
Published: (2007)

Allometric scaling of therapeutic monoclonal antibodies in preclinical and clinical settings
by: Eva Germovsek, et al.
Published: (2021)

Monoclonal antibodies as potent therapeutics in dentistry.
by: Pratichi Tripathi, et al.
Published: (2019)

Monoclonal antibodies used in rheumatologic disorders
by: V Ravichandra, et al.
Published: (2013)

Advances in the progress of monoclonal antibodies for rabies
by: Linlin Fan, et al.
Published: (2022)

Bibliometric analysis of monoclonal antibodies for atherosclerosis
by: Jiqing Ma, et al.
Published: (2023)

MYTHS AND FACTS OF BIOSIMILAR MONOCLONAL ANTIBODIES
by: João Gonçalves
Published: (2015)

The pharmacology and therapeutic applications of monoclonal antibodies
by: María Sofía Castelli, et al.
Published: (2019)

The Role of Monoclonal Antibodies in the Management of Leukemia
by: Mohamad Cherry, et al.
Published: (2010)

Monoclonal antibodies used in rheumatologic disorders
by: V Ravichandra, et al.
Published: (2013)

Beyond statistical significance
by: N Gopi Chander
Published: (2019)

The Role of Monoclonal Antibodies in the Treatment of Myeloma Kidney Disease
by: Daniele Derudas, et al.
Published: (2024)

Virus inoculation and treatment regimens for evaluating anti-filovirus monoclonal antibody efficacy in vivo
by: Logan Banadyga, et al.
Published: (2019)

Monoclonal gammopathy of undetermined significance-associated scleromyxoedema
by: Kalgi D Baxi, et al.
Published: (2019)

The Disease is Indicated For the Icu, But the Patient is Not..., Dear Colleague
by: Einstein Francisco Camargos
Published: (2024)

Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume
by: M. Desai, et al.
Published: (2023)

Tolerability of calcitonin gene-related peptide monoclonal antibodies and other monoclonal antibodies in adults with concurrent migraine and other medical conditions
by: Kevin Weber, et al.
Published: (2024)

Monoclonal antibodies blocking CGRP for prevention of migraine
by: Alicja Maziarczyk, et al.
Published: (2023)

Analytical Techniques for the Characterization and Quantification of Monoclonal Antibodies
by: Hassan A. Alhazmi, et al.
Published: (2023)

Future directions in cancer immunotherapy with monoclonal antibodies
by: Lucía Cabello-Alemán
Published: (2022)

Customer-centric product presentations for monoclonal antibodies
by: Beate Bittner
Published: (2023)

Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE)
by: Gabriella Moroni, et al.
Published: (2010)

Safety issues of monoclonal antibodies used in rheumatology
by: A. V. Philippova, et al.
Published: (2020)

Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers
Published: (2022)

Development of Antibody Arrays for Monoclonal Antibody Higher Order Structure Analysis
by: Xing eWang, et al.
Published: (2013)

Statistical Significance and/or Effect Size?
by: Tina Štemberger
Published: (2021)

Data interpretation and statistical significance
by: S M Balaji
Published: (2019)